Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
6
×
national blog main
biotech
life sciences
national top stories
new york blog main
san francisco blog main
san francisco top stories
boston
new york top stories
seattle blog main
abeona therapeutics
affordable care act
agios pharmaceuticals
alirocuma
alzheimer's
ameet nathwani
arches
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
david schenkein
deals
debate
detroit blog main
detroit top stories
digital
donald trump
drug price
econmoic impact
elimination
fda
food and drug administartion
georgia
glioblastoma
gv
iclaprim
indiana blog main
indiana top stories
What
based
6
×
bio
u.s
american
best
biosciences
continue
crash
debate
healthcare
industry
kind
medicines
nash
new
people
pharmaceutical
policy
politicians
pressure
roundup
scalps
tiny
trump’s
aims
amazon
approach
available
bay
begin
big
biotech
bio’s
brings
bubbles
called
cas
cells
cheaper
class
Language
unset
Current search:
xconomy.com
×
based
×
" boston top stories "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
CVS Health Expands Delivery, as Pharmacies Try to Keep Amazon at Bay
